JP2025504019A - 部位特異的遺伝子編集のためのセリンリコンビナーゼシステム - Google Patents

部位特異的遺伝子編集のためのセリンリコンビナーゼシステム Download PDF

Info

Publication number
JP2025504019A
JP2025504019A JP2024544897A JP2024544897A JP2025504019A JP 2025504019 A JP2025504019 A JP 2025504019A JP 2024544897 A JP2024544897 A JP 2024544897A JP 2024544897 A JP2024544897 A JP 2024544897A JP 2025504019 A JP2025504019 A JP 2025504019A
Authority
JP
Japan
Prior art keywords
recombinase
bxb1
variant
cell
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024544897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504019A5 (https=
Inventor
アラングンディ，セバスチャン
エー． ファウザー，フリードリヒ
シー． ミラー，ジェフリー
スカーロット，ニコラス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sangamo Therapeutics Inc
Original Assignee
Sangamo Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangamo Therapeutics Inc filed Critical Sangamo Therapeutics Inc
Publication of JP2025504019A publication Critical patent/JP2025504019A/ja
Publication of JP2025504019A5 publication Critical patent/JP2025504019A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/22—Endodeoxyribonucleases producing 3'-phosphomonoesters (3.1.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2024544897A 2022-01-28 2023-01-27 部位特異的遺伝子編集のためのセリンリコンビナーゼシステム Pending JP2025504019A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263304565P 2022-01-28 2022-01-28
US63/304,565 2022-01-28
PCT/US2023/061500 WO2023147507A1 (en) 2022-01-28 2023-01-27 Serine recombinase systems for site-specific gene editing

Publications (2)

Publication Number Publication Date
JP2025504019A true JP2025504019A (ja) 2025-02-06
JP2025504019A5 JP2025504019A5 (https=) 2026-02-04

Family

ID=85328719

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024544897A Pending JP2025504019A (ja) 2022-01-28 2023-01-27 部位特異的遺伝子編集のためのセリンリコンビナーゼシステム

Country Status (9)

Country Link
US (1) US20250243512A1 (https=)
EP (1) EP4469569A1 (https=)
JP (1) JP2025504019A (https=)
KR (1) KR20240135617A (https=)
CN (1) CN118591625A (https=)
AU (1) AU2023214005A1 (https=)
CA (1) CA3243345A1 (https=)
IL (1) IL314478A (https=)
WO (1) WO2023147507A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121693564A (zh) 2023-06-26 2026-03-17 夏威夷大学 进化的整合酶和其用于基因组编辑的方法
WO2025160202A1 (en) * 2024-01-22 2025-07-31 Arc Researrch Institute Engineered large serine recombinases
WO2025212976A2 (en) * 2024-04-03 2025-10-09 Sangamo Therapeutics, Inc. Engineered modular recombinase compositions, methods, and systems for site-specific dna recombination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202006462D0 (en) * 2020-05-04 2020-06-17 Mote Res Limited Modifying genomes with integrase

Also Published As

Publication number Publication date
IL314478A (en) 2024-09-01
CA3243345A1 (en) 2023-08-03
EP4469569A1 (en) 2024-12-04
CN118591625A (zh) 2024-09-03
WO2023147507A1 (en) 2023-08-03
AU2023214005A1 (en) 2024-08-15
KR20240135617A (ko) 2024-09-11
US20250243512A1 (en) 2025-07-31

Similar Documents

Publication Publication Date Title
JP6840796B2 (ja) Ｄｎａ結合ドメインと切断ドメインとを連結するための組成物
JP2025504019A (ja) 部位特異的遺伝子編集のためのセリンリコンビナーゼシステム
JP7012650B2 (ja) Ｄｎａ結合ドメインと切断ドメインとを連結するための組成物
JP6170080B2 (ja) 異常ヘモグロビン症の治療のための組成物および方法
CN105940013B (zh) 用于治疗血友病的方法和组合物
CA3163714A1 (en) Compositions and methods for the targeting of pcsk9
CA3009727A1 (en) Compositions and methods for the treatment of hemoglobinopathies
US20240026386A1 (en) Compositions and methods for the targeting of bcl11a
CN110997924A (zh) 用于在肝中表达感兴趣的蛋白的平台
CN111718420A (zh) 一种用于基因治疗的融合蛋白及其应用
CN117412775A (zh) 通过Cas与DNA聚合酶的关联增强可预测和无模板的基因编辑
JP2025535368A (ja) 逆転写酵素を含む遺伝子編集システム
Koodamvetty et al. Advancing Precision Medicine: Recent Innovations in Gene Editing Technologies
KR20190122596A (ko) 염기 교정용 유전자 구조체, 이를 포함하는 벡터 및 이를 이용한 염기 교정 방법
US20240398985A1 (en) Novel transcription factors
WO2023220654A2 (en) Effector protein compositions and methods of use thereof
WO2025024285A1 (en) Compositions for the modification of the human c9orf72 gene
WO2023004411A1 (en) A method for in vivo gene therapy to cure scd without myeloablative toxicity
WO2025212976A2 (en) Engineered modular recombinase compositions, methods, and systems for site-specific dna recombination
HK40076804A (en) Compositions and methods for the targeting of pcsk9
HK1262757A1 (en) Compositions for linking dna-binding domains and cleavage domains
HK1262757B (en) Compositions for linking dna-binding domains and cleavage domains
HK1240617A1 (en) Genome editing using campylobacter jejuni crispr/cas system-derived rgen

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260127